OncoVarMan retweeted
We are very excited to be included in SPARK Norway innovation program with our project of mathematical biomarkers for cancer. @OCBE_UniOslo @freeges @Vesselinka @l_schmiester @prat_aleix @fara_bm @YounessAzimzade
This Post is from an account that no longer exists. Learn more
OncoVarMan retweeted
How to pave the way for more outstanding research after an EU coordinator project? med.uio.no/klinmed/english/a…
OncoVarMan retweeted
Great collaboration with @valeria_vitelli, @ManuelaZucknick, @freeges, and @Vesselinka. Fun to be part of a project so heavily focused on Bayesian statistics!
🖥️A novel rank-based Bayesian clustering method on RNA-seq data from 12 Cancer Genome Atlas tumor types identified robust clusters
✔️Mostly reflects tissue of origin
✔️Includes pan-cancer clusters
👉buff.ly/3HtPRI4
#Transcriptomics #Oncoalert
#CompBio #Bioinformatics
OncoVarMan retweeted
Join us in congratulating BCRF investigator Dr. Chuck Perou, who receives the @AACR Distinguished Lectureship in Breast Cancer Research today at #SABCS22 for his impactful work. @SABCSSanAntonio
OncoVarMan retweeted
So happy to finally see the peer-reviewed version of our manuscript "Cis-regulatory mutations associate with transcriptional and post-transcriptional deregulation of gene regulatory programs in cancers" out.
doi.org/10.1093/nar/gkac1143
OncoVarMan retweeted
Unanimiter Et Constanter! Thank you @Vesselinka @freeges and all participants for a super hyggelig Xmas meeting 😍 @OCBE_UniOslo
OncoVarMan retweeted
Salim Ghannoum opening the traditional Christmas 🎄joint seminar between the groups of @Vesselinka @freeges @AlvaroKohn @XahTekK @TF_82 @AMathelier Thanks for another great year and precious collaboration @OCBE_UniOslo @frognerseteren
OncoVarMan retweeted
Steffan Bos-Haugen presenting our AnteNor collaboration at the Breast Cancer Association Consortium in Leiden @SteffanBos @Vesselinka
OncoVarMan retweeted
Registration is now open. Early-bird deadline is 15 July 2022 norbioinfo.no. #NBD22 #bioinformatikk @NorbisNorway @elixirnorway @RSGNorway @II_UiB
@forskningsradet @cbu_bergen @NCMMnews @Tekna
OncoVarMan retweeted
New position available in RESCUER: Funded Doctoral (PhD) position: Characterization
and functional validation of epigenetic changes
implicated in the response to cancer
immunotherapy, Paris, France rescuer.uio.no/news-and-even…
OncoVarMan retweeted
Learn how single-cell DNA sequencing and multi-omics are used to dissect clonal architecture, providing valuable insights for clinical strategies, therapeutic resistance, disease modeling, and the development of cell and gene therapies --> missionbio.com/single-cell-s…
OncoVarMan retweeted
Join us on Monday @Litteraturhuset for this exciting event about precision medicine. I will be speaking about digital twins for personalized cancer medicine @OCBE_UniOslo @UniOslo_MED @UiO_LifeSci
This Post is from an account that no longer exists. Learn more
OncoVarMan retweeted
Are you curious about how to apply Machine Learning to your project? Then check what Amani @amy23_O and the Riegler's group @simula_research are preparing as part of their DLN @DigitaltLiv transdisciplinary grant!
Hope to see you all ! Register here:
digitallifenorway.org/resear…
OncoVarMan retweeted
🎉🍾Nature Reviews Cancer is 20! To celebrate we have put together an anniversary issue with articles that look towards the future of cancer research. All reviews, perspectives and commentaries in the issue are FREE to access for 1 month starting today.
go.nature.com/3uhO8gN
OncoVarMan retweeted
We have a 2-year funded research/lab technician position available @NCMMnews @UniOslo_MED to implement experimental work, primarily CAGE assay to patient material. Cool project where you could also get exposed to computational biology
Info and application jobbnorge.no/en/available-jo…
OncoVarMan retweeted
Tumor heterogeneity is an important characteristic of cancer and a determinant of prognosis and treatment outcome. Emerging spatial transcriptomics data hold the potential to further our understanding of tumor heterogeneity and its implications. academic.oup.com/bioinformat…
OncoVarMan retweeted
Are you good in immunology, molecular biology or cellular biology? Do you want to join RESCUER? Check our new position
linkedin.com/feed/update/urn…
OncoVarMan retweeted
Into #rstats and want a PhD in #statisticalgenetics with medical applications? Come work with us in Oslo! Application deadline Aug 31. (Please RT!)
2411.webcruiter.no/Main2/Rec…
OncoVarMan retweeted
New in Genome Medicine: Olbrecht, @LambrechtsDlab, Vergote and colleagues - using scRNA-seq to identify stromal cell phenotypes -predicts overall survival in high-grade serous tubo-ovarian #cancer patients @vib_ccb, KU Leuven
https://xitter.cf/t.co/kQLY0IiwLO

























